Probiotic Blends Synergistic Gut Colonization Baby Food
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current probiotic technologies face challenges in maximizing beneficial effects on human health, particularly in vulnerable groups like infants and lactating mothers, due to variability in probiotic strain performance across different culturing media and lack of consideration for food substrate impact, with limited evidence on synergistic interactions and antagonistic activities between strains.
Innovation Solution
Development of probiotic blends comprising specific strains of Lactobacillus rhamnosus, Bifidobacterium breve, and Bifidobacterium animalis subsp. lactis or Lactobacillus gasseri, designed to enhance survival and colonization in the gut when administered with food, leveraging synergistic interactions to improve adhesion and pathogen displacement capabilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If single probiotic strains are used, then the formulation is simple and easy to manufacture, but the beneficial effect on human health is limited
Solution Approach 1:
The patent combines multiple probiotic strains (Lactobacillus rhamnosus, Bifidobacterium breve, and Bifidobacterium animalis subsp. lactis or Lactobacillus gasseri) into a single formulation to achieve synergistic effects. This merging of strains resolves the contradiction by improving health benefits through strain interaction while maintaining a defined, manageable formulation structure.
Solution Approach 2:
The probiotic blend creates a composite microbial formulation where different strains work together. This composite approach enhances the overall probiotic effect beyond what single strains can achieve, addressing the limitation of single-strain formulations while maintaining a structured, developable product.
2Measurement precision
If probiotics are tested on laboratory media, then the testing process is simple and fast, but the results do not reflect actual performance in food substrates
Solution Approach 1:
The patent changes the testing parameter from standard laboratory media to actual food substrates (milk, infant formula). This parameter change ensures that probiotic performance is evaluated under realistic conditions, accurately reflecting how the strains will perform in actual consumption scenarios while accounting for food matrix interactions.
Solution Approach 2:
The patent performs preliminary screening on laboratory media followed by confirmation testing in food substrates. This preliminary action allows for initial strain selection using simple methods, then validates performance in realistic conditions, balancing testing efficiency with accuracy.
3Productivity
If probiotic strains are selected for maximum growth in laboratory media, then the production efficiency is high, but the survival and colonization ability in the gut is not optimized
Solution Approach 1:
The patent changes the selection parameter from growth rate in laboratory media to survival and colonization ability in food substrates and gut conditions. This parameter change ensures that strains are selected for their actual probiotic performance in the human digestive system rather than just their growth characteristics in artificial media.
Solution Approach 2:
The patent uses laboratory media as a preliminary screening tool that is discarded after initial selection, then transitions to food substrate testing for final strain selection. The laboratory media serves as a disposable, low-cost initial filter before committing to more complex and expensive food-based validation.
4Reliability
If synergistic interactions between strains are assumed without verification, then the formulation development is faster, but the actual beneficial effect may be compromised by antagonistic activity
Solution Approach 1:
The patent implements feedback mechanisms by testing strain combinations in food substrates to verify synergistic effects. This feedback loop allows the development team to confirm whether selected strains work together beneficially or exhibit antagonism, enabling data-driven formulation optimization rather than relying on assumptions.
Solution Approach 2:
The patent tests more strain combinations than strictly necessary by evaluating multiple potential blends (Lactobacillus rhamnosus with Bifidobacterium breve, and alternatively with Bifidobacterium animalis subsp. lactis or Lactobacillus gasseri). This excessive testing approach ensures that the most effective synergistic combination is identified while accounting for potential antagonistic interactions.
Data Source
AI summary
The invention refers to a probiotic food supplement comprising a blend of strains of lactobacilli and bifidobacteria synergistically interacting with food (for instance milk) assuring thereby an improved beneficial effect on human health, with special reference to 0-6 months babies, weaning babies, breastfed and formula fed infants as well as lactating mothers. Synergistic blends, which may also be defined as synteractive, have been designed to maximise their probiotic action when assumed with milk and/or food, in whatever state or formulation.